Serpin B3/SCCA1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-46829
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Summary for Serpin B3/SCCA1 Antibody
Immunogen
This antibody was developed against Recombinant Protein corresponding to amino acids: KVLHFDQVTENTTEKAATYHVDRSGNVHHQFQKLLTEFNKSTDAYELK
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Serpin B3/SCCA1 Antibody
Immunohistochemistry: Serpin B3/SCCA1 Antibody [NBP2-46829]
Immunohistochemistry: Serpin B3/SCCA1 Antibody [NBP2-46829] - Staining of human vagina shows strong cytoplasmic and nuclear positivity in squamous epithelial cells.Applications for Serpin B3/SCCA1 Antibody
Application
Recommended Usage
Immunohistochemistry
1:50 - 1:200
Immunohistochemistry-Paraffin
1:50 - 1:200
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Serpin B3/SCCA1
Additional Serpin B3/SCCA1 Products
Product Documents for Serpin B3/SCCA1 Antibody
Product Specific Notices for Serpin B3/SCCA1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...